This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
Lung EpiCheck Biomarkers Development Study
-
Life Spring Clinical Research, Miami, Florida, United States, 33130
Emerald Coast OBGYN, Panama City, Florida, United States, 32405
Ochsner LSU Health Shreveport - Regional Urology, Shreveport, Louisiana, United States, 71106
Comprehensive Urology, Southfield, Michigan, United States, 48076
Michigan Institute of Urology, P.C., Troy, Michigan, United States, 48084
Urology San Antonio, San Antonio, Texas, United States, 78229
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
20 Years to 80 Years
ALL
Yes
Nucleix Ltd.,
2025-12-31